ES2125300T3 - Granulados farmaceuticos que contienen esteroides. - Google Patents

Granulados farmaceuticos que contienen esteroides.

Info

Publication number
ES2125300T3
ES2125300T3 ES93203476T ES93203476T ES2125300T3 ES 2125300 T3 ES2125300 T3 ES 2125300T3 ES 93203476 T ES93203476 T ES 93203476T ES 93203476 T ES93203476 T ES 93203476T ES 2125300 T3 ES2125300 T3 ES 2125300T3
Authority
ES
Spain
Prior art keywords
carrier
mixture
optionally
granules
desogestrel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93203476T
Other languages
English (en)
Inventor
Jan Hendrik Dopper
Der Ven Cornelis Josephus Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27578967&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2125300(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2125300T3 publication Critical patent/ES2125300T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA PREPARAR GRANULADOS QUE IMPLICA, PRIMERO, PREPARAR UN PORTADOR QUE COMPRENDE UN DILUYENTE, UN ENLAZANTE, Y OPCIONALMENTE UN AGENTE DESINTEGRANTE. EN UN CONTENEDOR SEPARADO DE DICHO PORTADOR, UN ESTEROIDE, LUBRICANTE Y, OPCIONALMENTE, UN ANTIOXIDANTE SE DISUELVEN EN UN DISOLVENTE ORGANICO OPCIONALMENTE PRECALENTADO. LA SOLUCION RESULTANTE SE AÑADE AL PORTADOR CONTENIDO DENTRO DE UN, V.G. MEZCLADOR DE VACIO, SEGUIDO ADEMAS POR UN AGITADO DE LA MEZCLA. EL DISOLVENTE ORGANICO SE ELIMINA DE LA MEZCLA. LA MEZCLA ADEMAS SE COMBINA PARA FORMAR GRANULOS. EL PROCESO PUEDE ADEMAS INCLUIR INCORPORAR UN INCREMENTADOR DE FLUJO TAL COMO UN DIOXIDO DE SILICONA COLOIDAL EN LOS GRANULOS. UN GRANULO PARA HACER UNA UNIDAD DE DOSIS FARMACEUTICA ES UN GRANO CARACTERIZADO EN QUE COMPRENDE: A) UN PORTADOR QUE COMPRENDE UN DILUYENTE Y UN ENLAZANTE, Y B) UNA PELICULA QUE REVISTE A DICHO PORTADOR, DICHA PELICULA COMPRENDE DESOGESTREL Y UN LUBRICANTE, Y TIENE LA CARACTERISTICA DE RETENER UN90 % DEL DESOGESTREL A UNA PRESION DE 150 MBAR Y A UNA TEMPERATURA DE 70
ES93203476T 1992-09-04 1993-12-10 Granulados farmaceuticos que contienen esteroides. Expired - Lifetime ES2125300T3 (es)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US07/941,026 US5395627A (en) 1992-09-04 1992-09-04 Pharmaceutical granulate
EP93203476A EP0657161B1 (en) 1992-09-04 1993-12-10 Pharmaceutical granulate containing steroids
FI935584A FI111221B (fi) 1992-09-04 1993-12-13 Menetelmä farmaseuttisten rakeiden valmistamiseksi
ZA939337A ZA939337B (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
NO934584A NO306928B1 (no) 1992-09-04 1993-12-13 Fremgangsmåte for fremstilling av steroidholdige granuler, samt granuler og tablett
NZ250443A NZ250443A (en) 1992-09-04 1993-12-13 Preparation of film coated, steroid-loaded granules
CA002111320A CA2111320A1 (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
AU52391/93A AU672447B2 (en) 1992-09-04 1993-12-14 Pharmaceutical granulate
JP32229093A JP3720385B2 (ja) 1992-09-04 1993-12-21 医薬顆粒
CN93121510A CN1050043C (zh) 1992-09-04 1993-12-29 药物颗粒

Publications (1)

Publication Number Publication Date
ES2125300T3 true ES2125300T3 (es) 1999-03-01

Family

ID=27578967

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93203476T Expired - Lifetime ES2125300T3 (es) 1992-09-04 1993-12-10 Granulados farmaceuticos que contienen esteroides.

Country Status (15)

Country Link
US (2) US5395627A (es)
EP (1) EP0657161B1 (es)
JP (1) JP3720385B2 (es)
CN (1) CN1050043C (es)
AT (1) ATE173918T1 (es)
AU (1) AU672447B2 (es)
CA (1) CA2111320A1 (es)
DE (1) DE69322396T2 (es)
DK (1) DK0657161T3 (es)
ES (1) ES2125300T3 (es)
FI (1) FI111221B (es)
GR (1) GR3029273T3 (es)
NO (1) NO306928B1 (es)
NZ (1) NZ250443A (es)
ZA (1) ZA939337B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
IL113816A (en) † 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical preparations containing desogestral, their preparation and use
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
AU710710B2 (en) * 1995-06-22 1999-09-30 N.V. Organon Compressed dry-granulation desogestrel tablets
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
DE19652196A1 (de) * 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
EP0927556B1 (en) 1997-09-23 2000-08-30 Akzo Nobel N.V. Dosage units of steroids with a seal coating for the steroids
US6756366B1 (en) * 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
KR100899032B1 (ko) * 2000-12-14 2009-05-21 오르토-맥네일 파마슈티칼, 인코퍼레이티드 비결정형의 안정화제를 포함하는 스테로이드 호르몬 제품
US6630166B1 (en) 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
DK1275377T3 (da) * 2001-07-11 2003-10-06 Applied Pharma Res Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
JP4756153B2 (ja) * 2004-08-27 2011-08-24 富士製薬工業株式会社 低成分含量の錠剤の製造方法
CA2601773A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US20070248665A1 (en) * 2006-04-24 2007-10-25 Sherman Bernard C Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
JP5818219B2 (ja) * 2012-05-14 2015-11-18 塩野義製薬株式会社 ６，７−不飽和−７−カルバモイルモルヒナン誘導体含有製剤
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
CN103271927A (zh) * 2013-05-31 2013-09-04 南通联亚药业有限公司 一种改进口服避孕药含量均匀性三级稀释法的工艺
CN103271928A (zh) * 2013-05-31 2013-09-04 南通联亚药业有限公司 一种改进去氧孕烯稳定性的处方工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180560A (en) * 1976-10-26 1979-12-25 Syntex Corporation Inert core implant pellet
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
EP0300523B1 (en) * 1987-07-06 1991-08-14 Akzo N.V. Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.

Also Published As

Publication number Publication date
JP3720385B2 (ja) 2005-11-24
GR3029273T3 (en) 1999-05-28
US5395627A (en) 1995-03-07
EP0657161A1 (en) 1995-06-14
DE69322396T2 (de) 1999-07-29
CN1050043C (zh) 2000-03-08
NO934584D0 (no) 1993-12-13
NO306928B1 (no) 2000-01-17
FI935584A0 (fi) 1993-12-13
NZ250443A (en) 1995-07-26
AU5239193A (en) 1995-07-13
CN1104487A (zh) 1995-07-05
DE69322396D1 (de) 1999-01-14
DK0657161T3 (da) 1999-08-16
NO934584L (no) 1995-06-14
FI111221B (fi) 2003-06-30
US5527543A (en) 1996-06-18
AU672447B2 (en) 1996-10-03
JPH07196513A (ja) 1995-08-01
ZA939337B (en) 1994-10-13
ATE173918T1 (de) 1998-12-15
FI935584A (fi) 1995-06-14
EP0657161B1 (en) 1998-12-02
CA2111320A1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
ES2125300T3 (es) Granulados farmaceuticos que contienen esteroides.
KR950031056A (ko) 에스트로겐 및/또는 프로게스토겐을 투여하기 위한 eva로 이루어진 경피성 매트릭스 시스템
AU2095092A (en) New arylethylamine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
KR900013950A (ko) (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온 화합물 및 약학적 담체를 함유한 약학적 조성물
BE900241A (fr) Procede de preparation d'ester de a-acetoxyethyle de cefuroxime.
KR880001237B1 (ko) 베클로메타손 17,21-디프로피오네이트의 용매화합물의 제조방법
GR3023311T3 (en) 17B-(3-Furyl) and 17B-(4-pyridazinyl)-5beta,14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
DE60031557D1 (de) Steroide, ihre herstellung , pharmazeutische zusammensetzungen mit ihnen und verwendungen dieser verbindungen
EP0401894B1 (en) Freeze-dried, powdery cyclophosphamide composition, as well as process for its preparation
KR950016749A (ko) 약제용 과립 및 그 제조 방법
JPS57183777A (en) Preparation of mycophenolic acid derivative
US3133858A (en) Stable thiobarbituric acid solution
GEP20002095B (en) Antracycline Disaccharides, Process for Their Preparation and Pharmaceutical Compositions
MacGee et al. O-methylation of estrogens by thermal degradation of their tetramethylammonium salts
JPH03178906A (ja) 包接化合物の製造方法
TH14841EX (th) แกรนูลยา
Cunico et al. A Phenylcarbene Transfer System
GB2008096A (en) (2-Oxo-pyrrolidine-1)- and (2-oxo- piperidine-1) carboxylic acid hydrazides, process for the manufacture thereof, and pharmaceutical preparations containing them
US3629240A (en) 17beta-(1-cycloalkenyl) oxy-2alpha 3alpha-epithio-5alpha-androstanes
ATE30712T1 (de) 4-hydroxy-alpha-aethyl-benzhydrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
JPS54125651A (en) Monocyclic beta-lactam derivative and its preparation
JPS5655362A (en) Polyfunctional azide compound and its preparation
TH21945B (th) แกรนูลยา
JPS5626832A (en) Preparation of cyclopentenolone

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 657161

Country of ref document: ES